Eskata is a topical medication used to treat seborrheic keratoses, a type of noncancerous skin growth. An Eskata consent form is a legal document that outlines the risks, benefits, and alternatives of using Eskata for skin treatment. The form is used to obtain the patient's informed consent before the treatment is initiated.
The Eskata consent form will typically provide information about the Eskata medication being used, including its intended use, recommended application, and potential risks and side effects. The form may also include information about alternative skin treatments, as well as instructions for the proper use and storage of the medication.
Patients are encouraged to read the Eskata consent form carefully, ask any questions they may have, and discuss any concerns with their healthcare provider before agreeing to undergo the treatment. By signing the Eskata consent form, patients acknowledge that they have been informed about the treatment, its potential risks and benefits, and give their explicit consent for the treatment to proceed.